Cargando…
New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast
Psoriasis is a chronic inflammatory skin disease, most commonly resulting in the occurrence of red and silver scaly plaques. About 30% of psoriasis sufferers develop psoriatic arthritis (PsA), a disorder that presents with additional joint inflammation and other clinical features. At present, the mo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615921/ https://www.ncbi.nlm.nih.gov/pubmed/23569359 http://dx.doi.org/10.2147/DDDT.S32713 |